Sarah L Moore, AUD | |
130 Austine Dr Ste 210, Brattleboro, VT 05301-6994 | |
(028) 254-3922 | |
(802) 258-9512 |
Full Name | Sarah L Moore |
---|---|
Gender | Female |
Speciality | Qualified Audiologist |
Experience | 12 Years |
Location | 130 Austine Dr Ste 210, Brattleboro, Vermont |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982959821 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
231H00000X | Audiologist | (* (Not Available)) | Secondary |
231H00000X | Audiologist | SP-986-AU (Massachusetts) | Secondary |
231H00000X | Audiologist | 1450114555 (Vermont) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Brattleboro Hearing Center Inc | 9234453200 | 4 |
Brattleboro Hearing Center Inc | 9234453200 | 4 |
Brattleboro Hearing Center Inc | 9234453200 | 4 |
News Archive
The Princeton Center for Leadership Training (PCLT), in collaboration with long-time partner HiTOPS, was awarded a five-year, $4.8 million federal grant from the U.S. Department of Health and Human Services (HHS) to replicate and evaluate a teen sexual health peer education program, known as the Teen Prevention Education Program (Teen PEP), in 16 high schools in rural North Carolina communities with high teen birth rates.
Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).
A study on the effects of hydroxychloroquinei n macaques infected with the SARS-CoV-2 virus, , used alone or in combination with azithromycin, have been pre-published on Research Square, after their submission to Nature.
The laboratory of SISSA's Laura Ballerini in collaboration with the University of Trieste, the University of Manchester and the University of Castilla -la Mancha, has discovered a new approach to modulating synapses.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
› Verified 6 days ago
Provider Name | Brattleboro Hearing Center Inc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1265835755 PECOS PAC ID: 9234453200 Enrollment ID: O20220725000356 |
News Archive
The Princeton Center for Leadership Training (PCLT), in collaboration with long-time partner HiTOPS, was awarded a five-year, $4.8 million federal grant from the U.S. Department of Health and Human Services (HHS) to replicate and evaluate a teen sexual health peer education program, known as the Teen Prevention Education Program (Teen PEP), in 16 high schools in rural North Carolina communities with high teen birth rates.
Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).
A study on the effects of hydroxychloroquinei n macaques infected with the SARS-CoV-2 virus, , used alone or in combination with azithromycin, have been pre-published on Research Square, after their submission to Nature.
The laboratory of SISSA's Laura Ballerini in collaboration with the University of Trieste, the University of Manchester and the University of Castilla -la Mancha, has discovered a new approach to modulating synapses.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
› Verified 6 days ago
Mailing Address | Practice Location Address |
---|---|
Sarah L Moore, AUD 130 Austine Dr Ste 210, Brattleboro, VT 05301-6994 Ph: (802) 254-3922 | Sarah L Moore, AUD 130 Austine Dr Ste 210, Brattleboro, VT 05301-6994 Ph: (028) 254-3922 |
News Archive
The Princeton Center for Leadership Training (PCLT), in collaboration with long-time partner HiTOPS, was awarded a five-year, $4.8 million federal grant from the U.S. Department of Health and Human Services (HHS) to replicate and evaluate a teen sexual health peer education program, known as the Teen Prevention Education Program (Teen PEP), in 16 high schools in rural North Carolina communities with high teen birth rates.
Doctors from the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National Health System have completed a clinical trial that demonstrates how osteoid osteoma, a benign but painful bone tumor that commonly occurs in children and young adults, can be safely and successfully treated using an incisionless surgery method called magnetic resonance-guided high-intensity focused ultrasound (MR-HIFU).
A study on the effects of hydroxychloroquinei n macaques infected with the SARS-CoV-2 virus, , used alone or in combination with azithromycin, have been pre-published on Research Square, after their submission to Nature.
The laboratory of SISSA's Laura Ballerini in collaboration with the University of Trieste, the University of Manchester and the University of Castilla -la Mancha, has discovered a new approach to modulating synapses.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
› Verified 6 days ago
John R Meisner, MS CCC A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 209 Austine Dr, Brattleboro, VT 05301 Phone: 802-254-3922 Fax: 802-258-9512 |